Last reviewed · How we verify
20% mannitol solution, 125 ml, IV infusion in 15 min — Competitive Intelligence Brief
marketed
Small molecule
Live · refreshed every 30 min
Target snapshot
20% mannitol solution, 125 ml, IV infusion in 15 min (20% mannitol solution, 125 ml, IV infusion in 15 min) — Capital Medical University.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| 20% mannitol solution, 125 ml, IV infusion in 15 min TARGET | 20% mannitol solution, 125 ml, IV infusion in 15 min | Capital Medical University | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- 20% mannitol solution, 125 ml, IV infusion in 15 min CI watch — RSS
- 20% mannitol solution, 125 ml, IV infusion in 15 min CI watch — Atom
- 20% mannitol solution, 125 ml, IV infusion in 15 min CI watch — JSON
- 20% mannitol solution, 125 ml, IV infusion in 15 min alone — RSS
Cite this brief
Drug Landscape (2026). 20% mannitol solution, 125 ml, IV infusion in 15 min — Competitive Intelligence Brief. https://druglandscape.com/ci/20-mannitol-solution-125-ml-iv-infusion-in-15-min. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab